Demonstrates the feasibility of using the Angiovac aspiration system as a bridge to surgery for high-risk patients with refractory active right-sided endocarditis on a bioprosthetic valve.
May support aspiration catheter as bridge in select refractory cases; case report leaves open safety/efficacy validation.
Guidelines for the treatment of active right-sided endocarditis are not well defined. We report the first novel use of an aspiration catheter system for transcatheter therapy of refractory active right sided endocarditis on a bioprosthetic valve in a high-risk surgical patient as a bridge to surgical intervention.
No takes yet. Share an insight, caveat, or question.
Divekar et al. (2012) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: